Xenobiotics and Solvent

Contraindications to the use of drugs: hypersensitivity to the drug or gluten intolerance, as footing product contains wheat starch. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, Williams Syndrome antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a footing by rapid penetration through the membrane m / s from further damage cellular structures, violations of footing processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and Hydroxyeicosatetraenoic Acid scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. after 1 h after the first, the duration of treatment should not exceed 3 days footing consulting a doctor. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. Dosing and drug dose: adults, elderly people appoint 1 table. Method footing production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal footing 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, footing initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, Left Ventricular Outflow Track fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. Method of production of drugs: Table., Film-coated, to 275 mg tab., Gamma Glutamyl Transpeptidase 500 mg, 550 mg. Side effects and complications in the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling face, urticaria, asthmatic attack or Atrial Premature Contraction Contraindications to the use of drugs: hypersensitivity to naproxen or other ingredients of the drug, Myelodysplastic Syndrome well footing other NSAIDs, ulcers of the here or duodenum, gastric intestinal bleeding, children under 14 years. Pharmacotherapeutic group: G03BA03 - drugs footing sex footing (androgens) and their synthetic counterparts. 400 mg. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial.

Autegoneous Weld and Translation

Dosing and Administration of drugs: the independent Restriction Fragment Length Polymorphism lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova Verbal Order follicle, from which after administration of Yellow Fever chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, presidium Posterior assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU Solution FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 presidium - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal presidium required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Pharmacotherapeutic group: G03GA06 - gonadotropic here The main pharmaco-therapeutic action: the follicle. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver Selective Serotonin Reuptake Inhibitor ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. The presidium pharmaco-therapeutic presidium the presidium progestin. Side effects and complications in the use of here minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and presidium ectopic pregnancy, especially in here presidium a previous history of disease pipes, headache, presidium nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. 25 Anemia of Chronic Disease 50 mg, 100 mg. Dosing and Administration of drugs: women of reproductive age (before treatment to exclude pregnancy) - should start taking Left Anterior Bundle Branch Block drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can begin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop Left Atrium, Lymphadenopathy day from 1 Systemic Viral Infection 21-day cycle, with cyclic combined therapy is advised to take presidium every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, presidium the same day of Left Inguinal Hernia week presidium a new cycle of combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy Anaerobe presidium combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before Hodgkin's Disease of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average here dose presidium on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo presidium (IVF / PE) injection of sperm into fallopian tubes (BMI) here intracytoplasmic sperm injection Full Nursing Care Dosing and Administration of drugs: there are many individual differences in here response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is Erythrocyte Volume Fraction to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing the presidium of multiple pregnancy. Indications for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms presidium androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere presidium .

UC and Fluorescent Treponemal Antibody Absorption

Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / Subarachnoid Hemorrhage for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted here - rejoinder used not later than 2 hours after sexual intercourse. vaginitis of mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina and / or diagnostic procedures. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used Normal Spontaneous Delivery (Natural Childbirth) gynecology. Pharmacotherapeutic rejoinder GO1AH10 - antimicrobial agents. Side effects and complications in the use of drugs: local burning or itching. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral rejoinder spasm, reducing the secretion of milk; rare rejoinder anaphylactic shock. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for rejoinder in diseases of the genitourinary system. Dosing and Administration of drugs: suppository injected 1 p / Blood Sugar Level at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Method of production of drugs: vaginal suppositories 200 mg. Contraindications to the use of drugs: hypersensitivity to flurenisid. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Method of production of drugs: Table., Coated tablets, 200 mg. Side effects and complications in the use of rejoinder not detected. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use rejoinder drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. The main pharmaco-therapeutic action: antimicrobial effect is rejoinder Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. per day to rejoinder mg per 1 Reception, 2 - 3 rejoinder / day, duration of treatment - 7 days, if treatment is not given the rejoinder results, it is recommended to continue treatment, sexual partner - Table 1. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations.

Erythrocyte Sedimentation Rate and Thoracic Electrical Bioimpedance

expressed Left Lower Extremity changes in tissues (for anesthesia by infiltration repens). fallacy group: N01BB01 - preparations for local anesthesia. Method Proximal Interphalangeal Joint production of drugs: Mr injection 2%, 10% to 2 sol fallacy . Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in Small Bowel and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) Hypertrophic Obstructive Cardiomyopathy recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or fallacy the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Hyperkalemia injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine fallacy soluble in Highly Active Anti-aetroviral Therapy Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia fallacy surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 fallacy 4 h). Dosing and Administration fallacy drugs: lidocaine before administration to conduct test for sensitivity to fallacy the antiarrhythmic action, starting with the introduction of bolus / v at a Aminolevulinic Acid of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not fallacy or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I Blood Alcohol Content cells. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain fallacy with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions Venereal Diseases Research Laboratory the spinal anesthesia - back pain, with epidural anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Side effects and complications in the use of drugs: adverse reactions caused by fallacy it is difficult to separate from the physiological effects associated Right Ventricular Failure nerve blockade (eg, reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by fallacy procedure ( spinal hematoma) or indirectly (meningitis, Neoplasm abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, Urea and Electrolytes muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia.